Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Xtant Medical Holdings (XTNT) over the last 16 years, with Q3 2025 value amounting to $600000.0.

  • Xtant Medical Holdings' Share-based Compensation fell 4545.45% to $600000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year decrease of 2726.62%. This contributed to the annual value of $4.1 million for FY2024, which is 5031.03% up from last year.
  • Xtant Medical Holdings' Share-based Compensation amounted to $600000.0 in Q3 2025, which was down 4545.45% from $800000.0 recorded in Q2 2025.
  • In the past 5 years, Xtant Medical Holdings' Share-based Compensation ranged from a high of $1.2 million in Q2 2024 and a low of $439000.0 during Q2 2023
  • Over the past 5 years, Xtant Medical Holdings' median Share-based Compensation value was $641000.0 (recorded in 2022), while the average stood at $717842.1.
  • As far as peak fluctuations go, Xtant Medical Holdings' Share-based Compensation surged by 17334.85% in 2024, and later tumbled by 4545.45% in 2025.
  • Xtant Medical Holdings' Share-based Compensation (Quarter) stood at $708000.0 in 2021, then fell by 9.75% to $639000.0 in 2022, then surged by 46.79% to $938000.0 in 2023, then dropped by 12.9% to $817000.0 in 2024, then dropped by 26.56% to $600000.0 in 2025.
  • Its Share-based Compensation was $600000.0 in Q3 2025, compared to $800000.0 in Q2 2025 and $800000.0 in Q1 2025.